The survey, published March 28 in JAMA Network Open, surveyed 204 oncologists between Nov. 15, 2022, and July 31, 2023.
Researchers found that 46.6% of oncologists said they received some education on AI use in healthcare, and 45.3% reported familiarity with clinical decision models. Of participants, 84.8% said AI-based clinical decision models needed to be explainable by oncologists but did not need to be explained to patients. However, 81.4% said patients should consent to the use of AI models to support treatment decisions.
Oncologists also said AI developers were responsible for medico-legal problems associated with AI use. About 76% of oncologists said they should protect patients from biased AI tools; however, only 27.9% said they were confident in their ability to identify poorly representative AI models.
At the Becker's Perioperative Summit, taking place October 29–31 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
